These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 9630323

  • 1. Unrelated donor marrow transplantation for inborn errors.
    Miano M, Porta F, Locatelli F, Miniero R, La Nasa G, Di Bartolomeo P, Giardini C, Messina C, Balduzzi A, Testi AM, Garbarino L, Lanino E, Crescenzi F, Zecca M, Dini G.
    Bone Marrow Transplant; 1998 Apr; 21 Suppl 2():S37-41. PubMed ID: 9630323
    [Abstract] [Full Text] [Related]

  • 2. Unrelated donor marrow transplantation in childhood: a report from the Associazione Italiana Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto Midollo Osseo (GITMO).
    Dini G, Cancedda R, Giorgiani G, Porta F, Messina C, Uderzo C, Pession A, Fagioli F, La Nasa G, Arcese W, Pollichieni S, Zecca M, Lanino E, Mazzolari E, Cesaro S, Balduzzi A, Rondelli R, Vassallo E, Cappelli B, Locatelli F, Association Italiana Ematologia e Oncologia Pediatrica and Gruppo Italiano per il Trapianto Midollo Osseo.
    Haematologica; 2002 Aug; 87(8 Suppl):51-7. PubMed ID: 12412391
    [Abstract] [Full Text] [Related]

  • 3. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N, Le Deist F, Cant A, De Graeff-Meeders ER, Fasth A, Morgan G, Vellodi A, Hale G, Bujan W, Thomas C, Cavazzana-Calvo M, Wijdenes J, Fischer A.
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [Abstract] [Full Text] [Related]

  • 4. [Unrelated donor stem cell transplantation in children: low toxicity using a GvHD-prophylaxis regimen with CSA, MTX, metronidazole,iv-immunoglobulin and ATG].
    Graf Finckenstein F, Zabelina T, Dürken M, Dahlke J, Kröger N, Krüger W, Janka-Schaub G, Erttmann R, Zander AR, Kabisch H.
    Klin Padiatr; 2002 Sep; 214(4):206-11. PubMed ID: 12165903
    [Abstract] [Full Text] [Related]

  • 5. Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Group (GITMO).
    Dini G, Cancedda R, Locatelli F, Bosi A, Bandini G, Alessandrino EP, Porta F, Uderzo C, Messina C, Fagioli F, Arcese W, Marenco P, Fanin R, Falda M, Soligo D, La Nasa G, Giardini C, Pession A, Scimè R, Di Bartolomeo P, Bruno B, Garbarino L, Lamparelli T, Giorgiani G, Lanino E, Manzitti C, Bacigalupo A, Italian Bone Marrow Transplant Group (GITMO).
    Haematologica; 2001 May; 86(5):451-6. PubMed ID: 11410406
    [Abstract] [Full Text] [Related]

  • 6. Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors.
    Martin P, Bleyzac N, Souillet G, Galambrun C, Bertrand Y, Maire PH, Jelliffe RW, Aulagner G.
    Bone Marrow Transplant; 2003 Nov; 32(9):881-7. PubMed ID: 14561988
    [Abstract] [Full Text] [Related]

  • 7. The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia.
    Byrne JL, Stainer C, Cull G, Haynes AP, Bessell EM, Hale G, Waldmann H, Russell NH.
    Bone Marrow Transplant; 2000 Feb; 25(4):411-7. PubMed ID: 10723585
    [Abstract] [Full Text] [Related]

  • 8. Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children: experience of eight European Countries. The EBMT Paediatric Diseases Working Party.
    Dini G, Rondelli R, Miano M, Vossen J, Gluckman E, Peters C, Bordigoni P, Locatelli F, Miniero R, Ljungman P, Saarinen U, Klingebiel T, Ortega J, Lanino E.
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():80-5. PubMed ID: 8932805
    [Abstract] [Full Text] [Related]

  • 9. Unrelated donor bone marrow transplantation for Fanconi anemia.
    Davies SM, Khan S, Wagner JE, Arthur DC, Auerbach AD, Ramsay NK, Weisdorf DJ.
    Bone Marrow Transplant; 1996 Jan; 17(1):43-7. PubMed ID: 8673053
    [Abstract] [Full Text] [Related]

  • 10. [Allogeneic bone marrow transplantation in children from related donors other than HLA-identical siblings].
    Morimoto T, Hattori K, Yabe H, Yabe M, Hinohara T, Shimizu T, Matsumoto M, Hagihara M, Tsuji K, Kato S.
    Rinsho Ketsueki; 1998 Sep; 39(9):631-9. PubMed ID: 9796395
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen.
    Matsuyama T, Kojima S, Kato K.
    Bone Marrow Transplant; 1998 Jul; 22(1):21-6. PubMed ID: 9678791
    [Abstract] [Full Text] [Related]

  • 13. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants.
    Al-Kasim FA, Thornley I, Rolland M, Lau W, Tsang R, Freedman MH, Saunders EF, Calderwood S, Doyle JJ.
    Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The role of thiotepa in allogeneic bone marrow transplantation for genetic diseases.
    Rosales F, Peylan-Ramu N, Cividalli G, Varadi G, Or R, Naparstek E, Slavin S, Nagler A.
    Bone Marrow Transplant; 1999 May; 23(9):861-5. PubMed ID: 10338039
    [Abstract] [Full Text] [Related]

  • 16. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
    Herrera C, Torres A, García-Castellano JM, Roman J, Martin C, Serrano J, Falcon M, Alvarez MA, Gomez P, Martinez F.
    Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Unrelated donor BMT recipients given pretransplant low-dose antithymocyte globulin have outcomes equivalent to matched sibling BMT: a matched pair analysis.
    Duggan P, Booth K, Chaudhry A, Stewart D, Ruether JD, Glück S, Morris D, Brown CB, Herbut B, Coppes M, Anderson R, Wolff J, Egeler M, Desai S, Turner AR, Larratt L, Gyonyor E, Russell JA, Alberta Blood and Bone Marrow Transplant Program.
    Bone Marrow Transplant; 2002 Nov; 30(10):681-6. PubMed ID: 12420207
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia.
    Kodera Y, Morishima Y, Kato S, Akiyama Y, Sao H, Matsuyama T, Kawa K, Sakamaki H, Nakagawa S, Hirabayashi N, Dohi H, Okamoto S, Hiraoka A, Gondo H, Tsuchida M, O H, Harada M, Asano S, Juji T, Sasazuki T, Takaku F.
    Bone Marrow Transplant; 1999 Nov; 24(9):995-1003. PubMed ID: 10556959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.